Clinical trials
Screening clinical trials
Below are recruiting screening clinical trials, each written for real people, not researchers. We’re tracking 946 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05700461RecruitingPhase 1
Testing a new implant drug delivery device for kidney cancer
This early-phase study tests a new small implant (“IMD”) that can deliver a drug for people with kidney cancer going to surgery. If you qualify, you would get the implant placed through the skin and later have it removed during your operation, along with extra lab checks and genetic testing.
Boston, MassachusettsAges 18 years+ - NCT05700877RecruitingPhase 4
Screening and treatment for silent heart artery disease in type 2 diabetes
This trial tests a screening and intervention approach for “silent” coronary artery disease (heart artery narrowing without major symptoms) in people with type 2 diabetes. It may help prevent future heart problems by finding higher-risk cases early and starting the right treatment plan.
OdenseAges 55–75 - NCT05704920Recruiting
AI-based support for lung cancer screening scans
This trial tests whether using artificial intelligence (computer pattern-recognition) with lung screening images can help identify people who may have lung cancer earlier. It’s meant for people at higher risk because of their smoking history, who can follow the screening steps.
Nice, Alpes-maritimesAges 18–80 - NCT05724264Recruiting
Lung cancer screening using CT and blood marker tests
This study tests whether combining low-dose chest CT scans with blood “biomarker” tests can help find lung cancer earlier in people at higher risk. You may be asked to have scans and blood tests and then attend follow-up visits over time.
SingaporeAges 50–80 - NCT05727228Recruiting
Risk screening for HPV after LEEP
This study looks at how to sort people into higher- or lower-risk groups after abnormal HPV testing treatment (LEEP), using repeat HPV and Pap (cytology) tests. It may help improve follow-up plans by identifying who needs closer monitoring after LEEP.
Randers, Central JutlandAges 23–64 - NCT05733416Recruiting
FDG PET/CT scan after unexplained stroke to find hidden cancer
This study checks whether doing an intensive scan using FDG PET/CT shortly after a “cryptogenic” (unexplained) ischemic stroke can uncover an underlying cause, such as cancer. If a hidden source is found earlier, it may help guide the next treatment steps.
Ottawa, OntarioAges 18 years+ - NCT05762731Recruiting
Lung cancer screening for people with family history
This trial offers screening tests to look for lung cancer early in people whose parent, child, or sibling has had lung cancer. It may help find cancer sooner, when treatment is more effective.
Hong Kong, Hong KongAges 50–75 - NCT05800132Recruiting
AI helps review routine breast mammograms for screening
This study tests whether an artificial intelligence (AI) system can help a second reader interpret routine breast screening mammograms. It may improve how consistently images are assessed, especially when the first reader calls them normal or benign.
AubagneAges 50–74 - NCT05810701Recruiting
Geriatric screening for newly diagnosed ovarian cancer patients
This study looks at older adults with newly diagnosed epithelial ovarian cancer and checks health factors that can affect treatment, like day-to-day function and support needs. It may help doctors choose better care plans for older patients by understanding risks and needs early.
Odense, Region of South DenmarkAges 70–120 - NCT05843851Recruiting
Newborn screening for rare cystinosis and hyperoxaluria
This study offers genetic screening to newborns to look for two rare metabolic conditions. It helps doctors find these conditions earlier, so treatment can start sooner if needed.
Hanover, Lower SaxonyAges 1 day–3 days - NCT05858528Recruiting
Study following adults with skin psoriasis over time
This observational study is looking at adults with skin psoriasis and collecting real-world information about their condition and experiences. It may help researchers better understand psoriasis and how it affects people, without giving a new treatment.
Oxford, OxfordshireAges 18 years+ - NCT05864794Recruiting
Screening brain MRI in advanced lung cancer patients
This trial looks at whether doing an MRI scan of the brain for people with stage IV lung cancer helps in their care. The goal is to find brain issues early (if present) so treatment decisions can be made sooner.
Groningen, Provincie GroningenAges 18 years+ - NCT05874466Recruiting
Screening app for autism signs in young children
This study tests whether a tablet/computer app can reliably spot early autism signs in toddlers. If it works well, it could help families and clinicians screen sooner and more accurately.
Durham, North CarolinaAges 1.3 years–3 years - NCT05891873Recruiting
Study delirium during ICU care for stroke patients
This study looks at “delirium,” a sudden confusion that can happen during critical care, in people receiving ICU treatment for stroke. It includes both adults and children in specific ICU settings and may help clinicians better prevent or manage confusion during recovery.
BrnoAges Any age - NCT05898594Recruiting
Lung cancer screening for high-risk Black adults
This study is designed to help Black adults at higher risk get lung cancer screening. It checks whether a screening approach can catch lung problems early and connect people to the right next steps.
Chicago, IllinoisAges 50–80 - NCT05899023Recruiting
Diabetes screening after an ER visit
This trial checks for signs of diabetes using a blood test (HbA1c) after an emergency room visit, then links eligible people to outpatient care. It may help you find diabetes earlier and get follow-up treatment sooner.
New York, New YorkAges 20–70 - NCT05909046Recruiting
Diabetes screening after childbirth and follow-up care study
This study checks how well diabetes screening done right after delivery works, and then offers follow-up care for participants later after birth. It may help you catch ongoing diabetes risk early and connect you to the right care.
Columbus, OhioAges 18 years+ - NCT05910580Recruiting
Screening and support for alcohol and substance risk in adults
This study aims to improve care access and outcomes for adults who screen positive for risky alcohol or drug use. If you qualify, you may be offered ways to connect to support during your reproductive years.
Boston, MassachusettsAges 18 years+ - NCT05915377Recruiting
Screening for hospital confusion in older adults
This trial is testing practical ways to recognize delirium, a sudden type of hospital confusion, in older patients. It may help your care team spot confusion earlier and respond sooner.
Boston, MassachusettsAges 70 years+ - NCT05916430Recruiting
Screening autism risk in 9-month-old infants
This trial checks how 8- to 10-month-old babies visually engage with people, which may help screen for autism risk earlier. It may help by improving early identification, especially for families who want screening done in a research setting.
Atlanta, GeorgiaAges 8 months–10 months - NCT05919342Recruiting
Screening for early heart failure in primary care or at home
This trial tests whether simple screening using a blood test (natriuretic peptides) plus an ultrasound of the heart (echocardiogram) can find early heart failure sooner. Finding it earlier may help doctors start the right management to prevent it from getting worse.
Cleveland, OhioAges 40 years+ - NCT05922176Recruiting
Microneedle patch testing to predict allergy treatment response
This study uses a small microneedle patch to collect skin-related samples to help predict how well allergy immunotherapy may work. It includes people with house dust mite allergy and also a healthy control group, so researchers can compare biomarker results.
SeoulAges 19–60 - NCT05963191Recruiting
Test camera bowel scan for early Lynch syndrome lesions
This study tests a special CAD-EYE system to help detect abnormal (potentially cancer-related) growths during colonoscopy in people with Lynch syndrome. It may improve how reliably clinicians find lesions early, when treatment can be easier.
ParisAges 18–90 - NCT05965115Recruiting
Screening study for family members of multiple myeloma patients
This trial screens first-degree relatives of people with multiple myeloma to check for early signs of the disease before symptoms. It may help doctors understand risk in families and find problems sooner if they occur.
Shanghai, Shanghai MunicipalityAges 18 years+
Hear when a new Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for screening?
- Yes. Clin2 currently lists 946 recruiting screening studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a screening trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a screening trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.